Plough Center for Sterile Drug Delivery Solutions
FDA and State of Tennessee Health Department Registered and Inspected for cGMP Compliance
FDA Registered for 503B Compounding with cGMP Quality Attributes
Rapid and Quality Turn Around for
- Comprehensive Sterile Formulation Solutions from Discovery, Preclinical to Clinical Manufacturing
- Final Dosage Labeling and Packaging
- Full Service Analytical Methods Development and Validation
- Aseptic Fill and Finish in Vials, Prefilled Syringes and Cartridges
- Organic and Aqueous Media Lyophilization
- Particle reduction via Homogenization and Extrusion
- Capability to handle Potent/Cytotoxic Compounds
- Monoclonal Antibodies, Liposomes, Lipid Nanoparticles and Emulsions
- ICH Stability Studies; CTM Storage and Limited Distribution
Our mission is to help patients by expediting efforts to bring innovative, life-saving medicines to market.
We stand at the forefront of quality, capability, flexibility, adaptability and client satisfaction, helping universities, scientific communities and industries deliver therapeutic advances to market that will improve the standard of care.
The Plough Center Difference
- Approximately 3,900 Sq. Ft. of Cleanroom Facility to Support All Stages
- Well Qualified PhD Level Operators Behind Fill Lines / Compounding
- Pharma Industry Experienced Leadership Behind Quality Operations
- State-of-the-art Barrier / Isolator Technology for Sterile Fill / finish
- Novel Formulation Platform for Nanoemulsions and Nanosuspensions
- Independent Analytical Services
- Designated Waters Corporation’s Center of Excellence for Demonstration
- Customer Oriented Team with Flexibility, Affordability, Adaptability and Quality
Plough Center Legacy Includes:
- All Operations, Documentation and Policies Compliant with US-FDA cGMP
- Sterile Liquid Vials
- Prefilled Syringes
- Ampoules
- Lyophilized Vials
- Kits with Ready-to-Use Diluents for Reconstitution
- Cytotoxics and Highly Potent Compounds
- Liposome Encapsulation Technology
- Injectable/ Infusible Nanoemulsions and Nanosuspensions
- Sterile Ophthalmic Formulations
- Single Use Quality Component Fill-Finish Technologies
- Isolator Technology for Aseptic Processing
- Terminal Sterilization
- Flexible Bio-manufacturing Solutions
- QbD Process Development and Optimization
- Process Validation and Tech Transfer
- Early and Late Stage Drug Development
- Clinical Batch Manufacturing
- Partnership Opportunities for Virtual/Start-up/Orphan Drug Companies
- Release Testing Analytical Services
- Analytical Method Development and Validation
- Drug Substance (API) and Drug Product Stability Studies